Rana R. McKay, Wanling Xie, Archana Ajmera, Christina Jamieson, Arlene Araneta, Edmund Folefac, Arif Hussain, Christos Kyriakopoulos, Adam C. Olson, Mamta Parikh, Rahul R. Parikh, Biren Saraiya, Lincoln W. Pasquina, Sarah Clifford, Merrida Childress, Amaya Gasco Hernandez, S. Percy Ivy, Eliezer Mendel Van Allen, Bose Kochupurakkal, Geoffrey Ira Shapiro. "A multicenter, randomized, phase 2, investigator-initiated ETCTN trial of olaparib + radium-223 vs. radium-223 in men with castration-resistant prostate cancer (CRPC) with bone metastases (BM) (COMRADE): Initial efficacy and biomarker analysis.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.5007